Form 4: Ginkgo Bioworks CFO Mark Dmytruk Reports Stock Transactions

CFO Mark Dmytruk reports transactions involving Ginkgo Bioworks Holdings, Inc. Class A and Class B Common Stock, including acquisitions, disposals, and conversions related to restricted stock units.

Summary

• Mark E. Dmytruk, CFO of Ginkgo Bioworks Holdings, Inc., filed a Form 4 detailing changes in beneficial ownership.
• The report includes transactions from February 3, 2025, and February 4, 2025.
• Dmytruk acquired Class A Common Stock through the vesting of restricted stock units (RSUs).
• He also converted Class B Common Stock to Class A Common Stock.
• A sale of 740 shares of Class A Common Stock at $13.443 per share occurred on February 4, 2025, to cover tax withholding obligations.
• Following the reported transactions, Dmytruk beneficially owns 33,963 shares of Class A Common Stock, and 15,411 shares of Class B Common Stock.
• The RSUs vest in 48 equal monthly installments, beginning on April 1, 2023, and April 1, 2024, respectively.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to investors regarding the trading activities of key personnel.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the sale of shares to cover tax obligations, but the overall impact is likely minimal.

Key Dates